Search research articles
Contact Us
Filters
Showing results (91-100 of 243) with videos related to
Page
of 25
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2023
Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data
Alice Boilève, Matthieu Faron, Sarah Fodil-Cherif, et al.
Nature Communications
|
September 2, 2021
Integrin-α<sub>V</sub>-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade
Ines Malenica, Julien Adam, Stéphanie Corgnac, et al.
JAMA Network Open
|
September 10, 2025
Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer
Adrien Rousseau, Noémie Simon-Tillaux, Stefan Michiels, et al.
Clinical and Translational Radiation Oncology
|
May 19, 2023
Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer
Antonin Levy, Jonathan Khalifa, Etienne Martin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 17, 2019
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors
Patrick Robelin, Julien Hadoux, Julien Forestier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2013
Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer
Emma Pailler, Julien Adam, Amélie Barthélémy, et al.
Frontiers in Immunology
|
November 10, 2022
Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case report
Mihaela Aldea, Rakiba Belkhir, Emeline Colomba, et al.
Cancer Chemotherapy and Pharmacology
|
February 24, 2016
Osimertinib Western and Asian clinical pharmacokinetics in patients and healthy volunteers: implications for formulation, dose, and dosing frequency in pivotal clinical studies
David Planchard, Kathryn H Brown, Dong-Wan Kim, et al.
NPJ Precision Oncology
|
July 17, 2021
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
Marianne Oulhen, Patrycja Pawlikowska, Tala Tayoun, et al.
Cardiovascular and Interventional Radiology
|
November 7, 2019
Correction to: Focus on Recommendations for the Management of Non-small Cell Lung Cancer
Pernelle Lavaud, Benjamin Besse, Thierry de Baere, et al.
Page
of 25
Search research articles
Search
Showing results (91-100 of 243) with videos related to
Sort By:
Page
of 25
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2023
Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data
Alice Boilève, Matthieu Faron, Sarah Fodil-Cherif, et al.
Nature Communications
|
September 2, 2021
Integrin-α<sub>V</sub>-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade
Ines Malenica, Julien Adam, Stéphanie Corgnac, et al.
JAMA Network Open
|
September 10, 2025
Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer
Adrien Rousseau, Noémie Simon-Tillaux, Stefan Michiels, et al.
Clinical and Translational Radiation Oncology
|
May 19, 2023
Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer
Antonin Levy, Jonathan Khalifa, Etienne Martin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 17, 2019
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors
Patrick Robelin, Julien Hadoux, Julien Forestier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2013
Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer
Emma Pailler, Julien Adam, Amélie Barthélémy, et al.
Frontiers in Immunology
|
November 10, 2022
Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case report
Mihaela Aldea, Rakiba Belkhir, Emeline Colomba, et al.
Cancer Chemotherapy and Pharmacology
|
February 24, 2016
Osimertinib Western and Asian clinical pharmacokinetics in patients and healthy volunteers: implications for formulation, dose, and dosing frequency in pivotal clinical studies
David Planchard, Kathryn H Brown, Dong-Wan Kim, et al.
NPJ Precision Oncology
|
July 17, 2021
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
Marianne Oulhen, Patrycja Pawlikowska, Tala Tayoun, et al.
Cardiovascular and Interventional Radiology
|
November 7, 2019
Correction to: Focus on Recommendations for the Management of Non-small Cell Lung Cancer
Pernelle Lavaud, Benjamin Besse, Thierry de Baere, et al.
Page
of 25